Immunotherapy of Crohn's disease
Although the initiating events of Crohn's disease are unknown, models of experimental colitis have provided new insights in the immunologically mediated pathways of mucosal inflammation. In Crohn's disease activated mucosal T lymphocytes produce proinflammatory cytokines within the mucosal...
Saved in:
| Main Authors: | C. van Montfrans, L. Camoglio, S. J. H. van Deventer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1998-01-01
|
| Series: | Mediators of Inflammation |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09629359891063 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01) -
The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients
by: Mateusz Makuch, et al.
Published: (2025-07-01) -
Influence of preoperative anti TNF alpha antibody therapy on postoperative recurrence of Crohn’s disease
by: Yuki Sekido, et al.
Published: (2025-04-01) -
Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion
by: S. Vassiliadis, et al.
Published: (1998-01-01) -
Biosimilar infliximab versus originator in Crohn’s
disease anti-TNF-α naïve and non-naïve patients
by: Magdalena Kaniewska, et al.
Published: (2020-11-01)